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mesoderm and urogenital tract. Loss of Pax2 in mice results in the complete absence of kidneys, ureters,
and sex speciﬁc epithelial structures derived from the intermediate mesoderm in both males and females.
In this report, we describe two new alleles of Pax2 created by inserting the enhanced green ﬂuorescent
protein coding region into the 5′ untranslated leader sequence. One allele is a hypomorph that generates
less protein and exhibits structural defects in kidneys and ureters upon homozygosity. A second allele is a
true null that can be used to image Pax2 expressing cells in a mutant background. Organ culture and embryo
analyses point to a loss of epithelial cell polarity and increased mobility in cells that have deleted Pax2 func-
tion. These experiments provide new insight into the role of Pax2 protein levels in determining correct renal
architecture and cell fate. These new Pax2 alleles are valuable genetic reagents for in vivo studies of urogenital
development.
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Congenital abnormalities of the kidneys and urogenital tract
(CAKUT) are among the most common developmental defects ob-
served in infants, with a frequency of 1 in 500, and often result in
end stage renal failure (Song and Yosypiv, 2011). Among the causes
of CAKUT are heterozygous mutations in the Pax2 gene, which lead
to Papillorenal Syndrome (OMIM #120330), also called Renal-
Coloboma Syndrome (Sanyanusin et al., 1995a, 1995b; Schimmenti
et al., 1995), and result in hypoplastic kidneys, vesicoureteral reﬂux,
progressive renal failure and optic nerve coloboma. Many different
mutations in Pax2 have been described, including frameshifts, mis-
sense mutations, and deletions, supporting the concept of a strict
gene dosage requirement for renal and optic nerve development
(Amiel et al., 2000; Fletcher et al., 2005; Martinovic-Bouriel et al.,
2010; Weber et al., 2006). Even within families carrying the same
mutation, not all aspects of the phenotype are observed and the de-
gree of penetrance varies. However, it is not clear how such a partial
loss of Pax2 activity begets structural and functional renal defects in
development or impacts adult physiology.
In the mouse, homozygous Pax2 deletions result in complete renal
agenesis because the nephric duct is abnormal and the metanephric
mesenchyme cannot respond to inductive signals (Brophy et al.,
2001; Torres et al., 1995). Pax2 is ﬁrst expressed shortly after gastrula-
tion in the region of intermediate mesoderm destined to form the
nephric duct, the mesonephric tubules, and the metanephricrights reserved.mesenchyme (Dressler and Douglass, 1992; Dressler et al., 1990).
The nephric duct is a single cell thick, columnar epithelial tube extend-
ing from about the 12th somite caudally toward the cloaca and ex-
presses both Pax2 and the closely related gene Pax8. While Pax2 null
mutants still form a nephric duct, Pax2/8 double homozygous null
mice fail to make the nephric duct and have little evidence of interme-
diatemesoderm (Bouchard et al., 2002). Surrounding the nephric duct
are Pax2 positive mesenchymal cells that form mesonephric tubules
more anterior and the metanephric mesenchyme along the posterior
aspect (Dressler, 2006, 2009). Adult kidney development begins
when an outgrowth of the nephric duct, the ureteric bud, invades
the metanephric mesenchyme, resulting in reciprocal inductive inter-
actions that promote ureteric bud branching and mesenchyme-to-
epithelial conversion (Costantini and Kopan, 2010). Pax2 continues
to be expressed in the ureteric bud epithelia and in the nephrons
progenitor cells that condense around the ureteric bud tips and be-
come the epithelial cells of the nephrons. Pax2 is also expressed in
the male speciﬁc derivatives of the mesonephric tubules, the vas
deferens and epididymus, and in the female derivatives of the parame-
sonpehric duct, the oviducts and endometrium of the uterus. All of
these sex-speciﬁc epithelia are deleted in Pax2 null embryos (Torres
et al., 1995).
Despite the need for Pax2 activity in urogenital development, it is
unclear how loss of Pax2 affects the ability to maintain epithelial cell
types or how decreased Pax2 activity results in gross structural abnor-
malities. In order to assess the fate of Pax2 positive cells during embry-
onic development, we inserted the enhanced green ﬂuorescent
protein (EGFP) coding region into the 5′ UTR of the mouse Pax2 gene
by homologous recombination. Two different alleles were created,
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leted. Surprisingly, the presence of PGK-neo results in a hypomorphic
allele that is homozygous viable, whereas the deletion of PGK-neo
generates a null allele. We utilized both alleles to study Pax2
expression in normal andmutant embryos and to examine the pheno-
types of embryos and adults with reduced Pax2 protein levels in the
hypomorphs. The results indicate a critical role for Pax2 inmaintaining
the epithelial integrity of the nephric duct. Furthermore, reduced
levels of Pax2 protein generate a spectrum of structural defects includ-
ingmultiple ureters, cystic kidneys, and fewer nephrons. Both of these
novel Pax2 alleles are useful for cell imaging, whereas the new Pax2
hypomorphic allele is also good mouse model that mimics multiple
aspects of CAKUT.
Materials and methods
Animals
The Pax2-Eneo targeting vector was created by fusing a 5′ BamHI-
NotI (4.1 kb) fragment to EGFP (pEGFP-1, Clonetech) and inserting a
PGK-neo cassette, ﬂanked by FRT recombinase site, downstream of
the EGFP SV40 poly A site. The 3′ Pax2 ﬂank was a 3.6 KB NotI-NcoI
fragment cloned downstream of PGK-neo. The vector had 2 HSV-TK
genes bordering the 5′ and 3′ ends of the Pax2 ﬂanking sequences. A
total of 60 μg of the targeting vector was linearized with SstI and
then electroporated into 2.4×107 ES R1 cells grown in DMEM supple-
mented with 15% fetal calf serum, 0.1 mM β-mercaptoethanol, 4 mM
glutamine, and 103 U/ml rLIF (Chemicon). Cells were plated onto
NeoR mouse embryonic ﬁbroblast feeders and selected with the same
media containing 0.3 mg/ml G418. The G418-resistant clones were
identiﬁed by Southern blot and the chromosome analysis was
performed to ensure the euploidy. Two targeted ES cell clones were
microinjected into donor blastocysts from C57BL/6×(C57BL/
6×DBA/2) F1 and the blastocysts were transferred into pseudopreg-
nant female recipients. Male chimeras were mated with C57BL/6 fe-
males, and germline transmission was identiﬁed by Southern blot of
tail DNA. Mice containing the entire targeting vector Pax2Eneo/+ were
mated with Flippase transgenic mice in order to excise PGK-neo cas-
sette from the targeting vector resulting in mice carrying the Pax2Egfp
allele.
For genotyping, tail DNA was prepared by a standard method,
and ampliﬁed by PCR using the following primer pairs: Eneo —
AGACTGCCTTGGGAAAAG, CCTATTCCGAAGTTCCTATTCTC; Egfp — GG
TTACAAATAAAGCAATAGCATC, TTGGAACCGAGACAGGAG; Pax2 — CCC
ACCGTCCCTTCCTTTTCTCCTCA, GAAAGGCCAGTGTGGCCTCTAGGGTG.
Western blotting
Cells were lysed in PK-lysis buffer (Cai et al., 2002) and protein
levels were quantiﬁed by the Bio-Rad colorometric assay (Bio-Rad,
Hercules, CA). SDS/PAGE sample buffer was added and samples were
boiled for 5 min. Samples were run on a 8% polyacrylamide gel, trans-
ferred to PVDF membrane (Perkin Elmer, Boston, MA), and blocked
with 5% non-fat milk in Tris-buffered saline. Membranes were immu-
noblotted with anti-Pax2 antibody (Dressler and Douglass, 1992) in
10 mMTris, pH 7.5, 100 mMNaCl, 0.1% Tween 20, 1% non-fat milk. Sec-
ondary antibodies conjugated to horseradish peroxidase were used at a
1:10,000 dilution, and the signal was visualized by chemiluminescence
(Amersham, Buckinghamshire, England).
In situ hybridization
Whole mount in situ hybridization was preformed as described
(Wilkinson, 1992). To allow better penetration of the probes the
nephrogenic tubules, duct andmesonephricmesenchymewere dissect-
ed from E11.5 embryos for whole mount analysis. The tissues wereﬁxed in 4% PFA overnight at 4 °C, dehydrated through a PBTX/Methanol
series, and stored at −20 °C until required. Digoxigenin (DIG) probes
were synthesized from plasmid templates using T7 or T3 polymerase.
The tissues were rehydrated, treated with proteinase K, reﬁxed
with 0.2% glutaraldehyde/4%PFA and hybridized overnight at 65 °C.
The following day the tissues were washed and blocked with 10%
lamb serum, 2%BSA in TBTX. The preabsorbed anti-DIG antibody
was incubated overnight at 4 °C. The samples were then washed for
two days and color was developed with NBT (4-nitro blue tetrazolium
chloride) and BCIP (X-phosphate/5-Bromo-4-chloro-3indolyl-phos-
phate) in NTMT (pH9.5).
Immunostaining
Embryos from timed matings were collected, imaged directly for
GFP ﬂuorescence, ﬁxed in 4% paraformaldehyde and embedded in
parafﬁn. Sections were cut at 5 μm, dewaxed and rehydrated. Anti-
gens were unmasked with VectaLabs Antigen retrival system by
microwaving on high for 10 min. Primary antibodies were incubated
for 2 h in PBS, 0.1% Tween-20, 2% goat serum followed by two washes
in PBS, 0.1% Tween-20. Goat anti-rabbit FITC or TRITC conjugates
(Sigma) were incubated for 1 h and washed. Micrographs were
taken with a Nikon ES800 ﬂuorescent microscope and digital Spot
camera. All exposure times were set manually and were equivalent
among sections. The antibodies used were: GFP (sc-9996, Santa
Cruz), laminin (Sigma), Crbs3 (Makarova et al., 2003), ZO1 (61-
7300, Zymed Labs), Dlg1 (VAM-PS005, Stressgen), Occludin1
(71-1500, Invitrogen), N-cadherin (05-915, Upstate Biotech.)
Live imaging
Embryos were dissected at various stages of development E9-E18.
Embryos and adult kidneys were examined and imaged with Leica
Stereoscope equipped with ﬂuorescence. Renal organ cultures were
carried out as previously described (Brophy et al., 2001). At E10.5,
whole intermediate mesoderms were isolated and cleaned from the
surrounding tissue. Samples were placed on transwell permeable sup-
ports from COSTAR (Costar, 0.4 μm pore size, Cat# 3450-clear) in a
homemade stainless steel adapter with a glass bottom 35mm culture
dishes (MatTek Corporation, part #: P35G-0-20-C) or glass bottom 6
well plates (MatTek Corporation, part # P06G-0-20-F). Organs were
cultured in DMEM supplemented with 10% fetal calf serum and penicil-
lin/streptomycin in 5% CO2 at 37 °C. Live images for movies were taken
using the Deltavision System (Applied Precision). Individual frames
were taken every 20 min. over a 24–48 hour period. Images were ac-
quiredwith SoftWoRx 3.5.1 software, automatically saved inDV format,
and then transferred to mpg format to make the movies.
Transmission electron microscopy
Embryos were ﬁxed with 2.5% glutaraldehyde in Sorenson's buffer
for 2 h at room temperature and were processed for transmission
electron microscopy following standard procedures. They were em-
bedded in PolyBed 812 resin (Polysciences™ Inc.), cut into 1-micron
slices and stained with toluidine blue. Sample areas were selected
based on the presence of developing kidneys and cut into ultra-thin
sections for analysis under a Philips CM-100 transmission electron
microscope. The selected TEM images are representative of at least
10 different images per embryo.
Results
Creation of two new Pax2 alleles
The Pax2 alleles used in the study are shown schematically
(Fig. 1A). A gene targeting vector was created that included the
Fig. 1. Pax2 EGFP insertional alleles. A) A schematic of the alleles used in this study. The ﬁrst two exons (e1, e2) of Pax2 are indicated by boxes, with the coding regions shaded.
Restriction sites are indicated by N, NotI; B, BamHI; H, HindIII; P, PstI; Bg, BglII. B) Total protein lysates from embryonic (E18.5) and newborn kidneys with the genotypes indicated
were western blotted and probed for Pax2, EGFP, and Tubulin as indicated. C) Bisected adult kidney from Pax2Eneo/Eneo homozygote showing large ﬂuid ﬁlled cysts. D) Two different
Pax2Eneo/Eneo homozygotes each with one normal and one hypoplastic kidney are shown. E) Bisected adult Pax2Eneo/Eneo kidney showing duplicated ureter and renal papilla with
EGFP expression in the papilla. F) Pax2Eneo/+ adult kidney bisected to show single papilla with EGFP expression. G and H) Urogenital system from Pax2Eneo/+ newborn mouse show-
ing strong EGFP in the nephrogenic zone. I and J) Urogential system form a male Pax2Eneo/Egfp mouse showing very rudimentary EGFP positive kidneys (k). Note the ureter (u) and
epidydimus (e) are present and are EGFP positive. K) Comparison of kidney size from Pax2Egfp/+ (top) and Pax2Egfp/Eneo (bottom) newborn mice.
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unique Not1 site upstream of the Pax2 translational start site. The
PGK-neo cassette is transcribed in the same orientation as Pax2 and
was ﬂanked by Flp recombinase recognition sites. Prior to removal
of PGK-neo, we called the allele Pax2Eneo. Upon crossing to an Flp
recombinase expressing deleter strain, we called the second allele
Pax2Egfp. Heterozygotes carrying each allele were crossed to generate
homozygous mice in a test for lethality. All of the Pax2Egfp/Egfp homo-
zygous newborns exhibited exencephaly, complete renal agenesis,
and died at birth similar to the Pax2−/− mice described previously
(Favor et al., 1996; Torres et al., 1995). However, Pax2Eneo/Eneo mice
were viable and fertile and were detected at normal Mendelian
frequencies. Thus, the Pax2Eneo allele still must have some Pax2 activ-
ity. Because the downstream exons were not disrupted by the EGFP
insertion, the possibility that the Pax2Eneo allele was making an
EGFP-Pax2 fusion protein was examined by western blotting from
late embryonic and newborn kidneys when Pax2 expression levels
are still high (Fig. 1B). The Pax2 protein was similar in size to the
wild-type. However protein expression levels were reduced in the
Pax2Eneo/Eneo homozygotes and were less than in the Pax2Egfp/+
newborns, whose kidneys did not show structural defects.
Despite their viability, it became apparent that Pax2Eneo/Eneo adult
mice were not normal and had a variety of renal defects, suggesting
that the Pax2Eneo was a hypomorphic allele. From 40 adult mice ana-
lyzed, structural renal abnormalities included 20% with medullary
cysts (Fig. 1C), 50% with unilateral hypoplasia (Fig. 1D), and 25%with duplicated ureters and lobular kidneys (Fig. 1E). Adult kidneys
that did not have congenital abnormalities were generally smaller
and had on average 36% fewer nephrons than wild-type, based on
glomerular counts of serial sections. However the density of glomer-
uli per unit area was not signiﬁcantly different between Pax2+/+
and the Pax2Eneo/Eneo adults (4.8±0.7 vs. 4.4±0.5 glomeruli/mm2 re-
spectively). In adult kidneys, EGFP expression was only observed in
the renal papilla (Fig. 1F), where Pax2 expression had been described
in the distal collecting ducts (Cai et al., 2005). In newborns,
EGFP expression was strong in the entire nephrogenic zone
where Pax2 expression and nephron differentiation are still ongoing
(Fig. 1H).
We also crossed the Pax2Eneo and Pax2Egfp mice to generate com-
pound heterozygotes, in an attempt to reduce Pax2 gene dosage
even further. However, all compound Pax2Eneo/Egfp newborns died at
birth presumably due to renal insufﬁciency, as the double
heterozygotes had very rudimentary kidneys (Fig. 1I–K). In contrast,
all Pax2Egfp/+ and Pax2Eneo/+ newborns were normal. These data fur-
ther support the conclusions that Pax2Eneo is a hypomorphic allele
with reduced levels of Pax2 protein.
Characterization of the Egfp expression patterns
Both new Pax2 alleles were examined for EGFP expression at
various stages of development (Fig. 2). Qualitatively, there is no
difference in the temporal and spatial pattern of EGFP, although
Fig. 2. EGFP expression in normal and Pax2mutant embryos. A) EGFP expression in Pax2Eneo/+ embryo perfectly mimics the endogenous pattern of Pax2 protein, including the mid-
brain–hindbrain junction (mh), the otic vesicle (o), the optic cup (c), and the nephric duct (n). Note branched EGFP positive structures at the posterior of the nephric duct (arrow).
B and C) Two different Pax2Eneo/+ E9.5 embryos with high magniﬁcation of the posterior nephric duct are shown. Note the cellular processes extending into the mesenchyme and
the branched structure of the tube. D) Dissected intermediate mesoderm from Pax2Eneo/+ E10.5 embryo showing EGFP positive nephric ducts (n) and the mesenchyme (m) of the
nephric cord running parallel to the ducts. Anterior is up. E) Dissected metanephric kidney from E11.5 Pax2Eneo/+ embryo. F and G) Two different E11.5 metanephric kidneys from
Pax2Eneo/Eneo E11.5 embryos are shown with duplication of the ureter (F, arrows) and a supernumerary ureteric bud (G, arrow). H) E11.5 Pax2Egfp/+ embryo has normal midbrain–
hindbrain and expresses EGFP in all Pax2 positive structures. I and J) A E11.5 Pax2Egfp/Egfp embryo exhibits exencephaly at the midbrain–hindbrain boundary, similar to germline
Pax2−/− embryos.
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Pax2Eneo. At E9.5, EGFP expression in Pax2Eneo heterozygotes is found
in the optic cup, otic vesicle, and the midbrain–hindbrain junction,
perfectly mimicking endogenous Pax2 protein. Nephric duct expres-
sion was also observed and revealed some unique features. Prior to
reaching the cloaca, the caudal end of the nephric duct showed bifur-
cations and cellular extensions. These cells at the tip of the growing
duct were not polarized epithelia and had characteristics of migrating
cells, with cellular processes extending into the surrounding mesen-
chyme as if the cells were sensing the environment and moving to-
ward a chemoattractant (Fig. 2B, C). Similar observations were
made by Chia et al. (2011), using a Hoxb7-GFP transgene expressed
in the developing nephric duct.
By E10.5 the nephric duct has reached the cloaca and the EGFP pos-
itive cells of the intermediate mesoderm are segregated into epithelial
duct cells and adjacent mesenchyme (Fig. 2D). The EGFP positive
mesenchyme was a continuous strip from anterior to posterior, as the
posterior metanephric mesenchymal aggregate had not yet separated
from the more anterior cells. By E11.5, EGFP is seen in the ureteric
bud and condensing mesenchyme of the metanephric kidney. In the
Pax2Eneo/Eneo homozygous mutants, evidence for double ureters or su-
pernumerary ureteric buds is seen in a fraction of kidneys (Fig. 2F,
G), consistent with the 25% frequency of lobular kidneys and multipleureters observed in adults. At E11.5, EGFP was very prominent in the
Pax2 positive neurons that were born at this time along the entire neu-
ral tube (Fig. 2H). At later stages of development, kidney epithelia, ure-
ters, and all the male and female speciﬁc epithelia derived from the
intermediate mesoderm were EGFP positive in Pax2Eneo/+ heterozy-
gotes. Homozygous Pax2Egfp/Egfp embryos also showed midbrain–hind-
brain defects and lacked kidneys (Fig. 2I, J), similar to previously
described embryos homozygous for the Pax2 null allele.
The percentage of kidneys with duplicate ureters in the
Pax2Eneo/Eneo homozygous embryos was surprising, since supernu-
merary ureters had not been describe in Pax2+/− embryos. In fact,
previous studies suggested a reduction in c-RET mRNA levels due to
loss of one Pax2 allele (Clarke et al., 2006). Thus, we examined the
Pax2Eneo/Eneo homozygotes for c-RET, Wnt11, and Spry1 expression
to determine potential changes in the genes that controlled or
responded to ureteric budding (Fig. 3). Levels of c-RET were not ap-
preciably different between WT and Pax2Eneo/Eneo at E11.5, as judged
by the intensity of whole mount in situ hybridization. Both the neph-
ric duct (arrowhead) and the ureteric bud (arrows) stained strongly
for c-RET. In cases of double ureters in Pax2Eneo/Eneo embryos, both
stained equally strong for c-RET. Spry1 expression was diminished
in the Pax2Eneo/Eneo mutants, especially in the nephric ducts (arrow-
head), but also in the ureter bud tips. Wnt11 expression was equally
Fig. 3. Ureteric bud gene expression in WT and Pax2Egfp/+ embryos. Whole mount in situ hybridization was done on regions of intermediate mesoderm dissected from E11–E11.5
embryos. Anti-sense DIG probes for the respective genes are listed above and the genotypes are given below the micrographs. The nephric ducts (arrowheads) and the ureteric bud
tips (arrows) are indicated. Note reduced staining for Spry1 in the nephric ducts and bud tips of the Pax2Egfp/Egfp mutant embryos.
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bud tips. These data suggest that a reduction of Spry1 expression
could be responsible for the ectopic ureters observed in approximate-
ly 25% of the Pax2Eneo/Eneo mice.
Loss of epithelial cell polarity in PaxEgfp/Egfp mutants
Given the strong EGFP ﬂuorescence in Pax2 expressing cells of
the intermediate mesoderm, we used this marker to study the phe-
notype of EGFP positive cells in the absence of Pax2 protein. In Pax2
null mutants, the nephric duct forms, due to the redundant function
of Pax8. However by E10.5, Pax8 expression is lost and the fate of the
nephric duct was not clear. Thus, we cultured regions of E10.5 inter-
mediate mesoderm on transwell ﬁlters and used time-lapse video
microscopy to follow the EGFP positive cells (Fig. 4A). At this stage,
Pax2Egfp/+ organ cultures showed a nephric duct, well-developed
mesonephric tubules, and a ureteric bud just beginning to invade
the metanephric mesenchyme. After two days in culture, the meta-
nephric development was more advanced with multiple branches
of the ureteric bud and condensing mesenchyme at the tips. The
nephric duct was intact and showed few alterations. In contrast,
the PaxEgfp/Egfp cultures exhibited marked differences. There was no
evidence of mesonephric tubules as the anterior EGFP positive mes-
enchyme slowly dissipated (Fig. 4A). The metanephric mesenchyme
was EGFP positive at time 0, but there was no evidence of a ureteric
bud. After 2 days in culture, this posterior metanephric mesenchyme
also was more diffuse with EGFP expression present but much less
intense than the Pax2Egfp/+ counterpart. Also after 2 days in culture,
the PaxEgfp/Egfp mutant nephric duct appeared very different from
Pax2 expressing wild-type nephric ducts. In the PaxEgfp/Egfp cultures,
the duct did not disappear, rather it was remarkably dynamic with
cell movements and many EGFP positive nodules growing in all di-
rections out from the duct, whereas the Pax2Egfp/+ duct remained
an intact single layer epithelial tube. This nodular appearance of
the nephric duct was not an artifact of organ culture, as intermediate
mesoderm dissected directly from E11.5 and E12.5 PaxEgfp/Egfp em-
bryos and imaged live also showed very similar nephric duct mor-
phology (Fig. 4B, C). Furthermore, the nodules observed in PaxEgfp/
Egfp mutant nephric ducts did not stain positive for c-RET expression,
at either E11.5 or E12.5, consistent with previous reports in Pax2
null embryos (Brophy et al., 2001).
Time lapse video microscopy revealed a number of unexpected
features in the nephric ducts of PaxEgfp/Egfp organ cultures (Fig. 5, sup-
plemental data). These ducts did not lose EGFP expression, rather the
positive cells were mobile and showed dynamic outgrowths and
cellular extensions protruding from the duct in all directions. These
cellular processes were followed by outgrowths of groups of cells toform the bumpy, disorganized duct. Frequently, EGFP positive cells
were seen leaving the epithelium of the duct completely and wander-
ing off into the surrounding mesenchyme. While these real time im-
ages are not true lineage traces, because EGFP expression
depends on continued Pax2 promoter activity, they do allow for the
visualization of cells that leave the duct for many hours afterwards.
In Pax2Egfp/+ cultures, no cells ever left the epithelium of the nephric
duct, which remained stable and intact. Another noteworthy feature
observed in the Pax2Egfp/+ cultures was the conversion of EGFP posi-
tive mesonephric mesenchyme cells, from the caudal end of the me-
sonephros, into epithelial, mesonephric tubules despite never
making contact with the nephric duct (Fig. 5G–I). The most caudal
mesonephric tubules are not connected to the duct, but it had not
been clear whether their conversion to epithelia required inductive
interactions. The real time imaging clearly rules out contact mediated
induction, as is the case in the metanephric mesenchyme.
In order to conﬁrm the dynamic changes in the nephric ducts of
Pax2Egfp/Egfp embryos and to characterize the cellular phenotype, we
examined E11.5 ducts by immunostaining of transverse sections
using markers for epithelial polarity (Fig. 6). As expected, Pax2
positive nephric ducts from Pax2Egfp/+ embryos consisted of a
single-cell, columnar epitheliumwith a well-deﬁned, laminin positive
basement membrane (Fig. 6A–C). The tight junction maker Zona
Occludins 1 (ZO1) was expressed in the sub-apical region between
all adjacent epithelial cells. In contrast, Pax2 negative nephric ducts
from Pax2Egfp/Egfp embryos showed multilayered regions with a dis-
continuous basement membrane and a coincident lack of ZO1 expres-
sion in some parts but not others. Transmission electron microscopy
revealed clear lack of cell–cell adhesions in the Pax2 mutant ducts,
as large gaps were evident between small areas of cell–cell contact
(Fig. 6D, H). Additional makers, Crumbs3 and Occludin1, of the sub-
apical tight junction show similar patterns of protein expression
with continuous sub-apical staining in normal duct epithelia but pat-
chy and variable staining in the Pax2Egfp/Egfp ducts (Fig. 6I, J, M, N).
Basolateral expression of Dlg3 appeared normal in wild-type but
was also reduced in mutant ducts (Fig. 6J, N). N-cadherin, a marker
of the mesenchyme was excluded from wild-type nephric ducts but
could be seen in a few cells from Pax2Egfp/Egfp ducts (Fig. 6K, O).
These data demonstrate that the nephric duct epithelium has either
failed to fully establish proper polarity or cannot maintain polarity
in the absence of Pax2.
Discussion
The Pax2 gene is critical for kidney development in all vertebrate
species examined to date (Favor et al., 1996; Majumdar et al., 2000;
Torres et al., 1995). In humans, Pax2 heterozygosity is associated
Fig. 4. Intermediate Mesoderm Cultures from Pax2Egfp/Egfp and Pax2Egfp/+ embryos. A) E10.5 dissected regions of intermediate mesoderm were laid ﬂat onto Transwell ﬁlters and
cultured for 2 days. EGFP expressing cells photographed over time at days 0, 1, and 2 as indicated. Note the dissolution of the mesonephric mesenchyme (m) and the metanephric
mesenchyme (mm) in the Pax2Egfp/Egfp cultures. Also note the distortion of the nephric duct epithelia (n). Pax2Egfp/+ cultures show a normally developing kidney (k) and an intact
nephric duct (n) over the 2 days in culture. B) E11.5 regions of intermediate mesoderm were dissected out and visualized for EGFP (left) and c-RET expression by whole mount in
situ (right). The nephric ducts are indicated (arrows). Note the strong c-RET expression in Pax2Egfp/+ whereas Pax2Egfp/Egfp show only background staining. C) Intermediate meso-
derm form E12.5 embryos dissected out and visualized for EGFP and c-RET as in B. Again, note the lack of c-RET in the Pax2Egfp/Egfp nephric ducts that exhibit the EGFP positive out-
growths. Pax2Egfp/+ embryos have turned c-RET off in the nephric duct but express in the ureteric bud tips of the developing kidney.
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boma (Eccles and Schimmenti, 1999; Schimmenti, 2011). However,
the penetrance of the phenotypes varies greatly, even within families
that carry the same Pax2 mutation. Variations in genetic background
may account for some of these differences, however in inbred strains
of mice, heterozygotes also show different degrees of hypoplasia, sug-
gesting that there are stochastic effects due to reduced gene dosage
(Cross et al., 2011; Favor et al., 1996; Keller et al., 1994).By inserting an EGFP-PGK-neo cassette into the 5′ UTR of Pax2, we
have created a hypomorphic allele that expresses less Pax2 protein
and exhibits a stronger phenotype, including smaller kidneys
and more congenital defects, when bred to homozygosity than a
Pax2+/− heterozygous genotype. Integrating reporter genes or Cre
recombinase into endogenous loci has proved a popular strategy for
marking cell types and for lineage tracing in vivo. Our EGFP alleles
do not permanently mark the lineage but EGFP is strong enough
Fig. 5. Real time imaging from E10.5 cultured intermediate mesoderm. Dissected regions of intermediate mesoderm from Pax2Egfp/Egfp and Pax2Egfp/+ E10.5 embryos were cultured
on transwell ﬁlters and imaged by time lapse video microscopy for 24 h. A–C) A series of images show an EGFP positive cell migrating laterally out of the nephric duct from a Pax2-
Egfp/Egfp organ culture (red arrow). D–F) Examples of cell movement in Pax2Egfp/Egfp organ cultures. Red arrows point to cellular processes that extend out of the nephric duct or cells
that have left the epithelium. Also note the irregular shape of the duct as cells becomemore mobile. G) Images from a Pax2Egfp/+ cultures show little movement of ductal epithelia. H
and I) Mesenchymal cells from the mesonephric region (blue arrows) condense and form epithelial tubules despite never making contact with the nephric duct. The complete
videos are available as supplementary data with 2 representative movies per genotype.
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after migration out of the nephric duct. However, the strategies for
inserting into non-coding regions and the use of selectable markers
can have unexpected consequences as in the PaxEneo allele, which ap-
pears to drive the endogenous, downstream Pax2 mRNA from the
PGK promoter. Since deletion of PGK-neo creates a true null allele, it
appears that the PGK-neo cassette is able to promote transcription
of Pax2 despite the presence of a poly-A addition signal at the 3′
end of the neo gene. The Pax2 mRNA generated by the Pax2Eneo allele
may be able to splice out the neo coding region and the associated
polyadenylation signal, although alternative mechanisms could exist
to create a translatable mRNA.
The hypomorphic phenotype observed in PaxEneo/Eneo mutants ex-
hibits some unique features. In addition to the hypoplasia, duplicate
ureters are seen in 25% of the kidneys. Ureteric budding is complex
process that requires RET/GDNF signaling, with RET expressing
nephric duct cells moving caudally and coalescing at the bud region
in response to activation by mesenchyme derived GDNF (Chi et al.,
2009). Ureteric budding is also suppressed by Spry1 (Basson et al.,
2005) and Bmp4 (Michos et al., 2007). Spry1 appears to negatively
regulate RET in the ureteric bud epithelium to limit budding and
branching to sites of maximum RET activation. Strikingly, in the ab-
sence of Spry1, there is no need for RET activation, as the alternative
tyrosine kinases of the FGF receptor family can substitute (Michos et
al., 2010). Based on whole mount in situ hybridization, we do not see
a reduction of RET or Wnt11 expression in the PaxEneo/Eneo mutant
ureteric buds. This is contrary to RT-PCR data reported previously in
Pax2+/− heterozygote embryos at various stages (Clarke et al.,
2006) and may reﬂect differences in cell number, timing, or Pax2expression levels among the different genotypes. It is worth noting
that Pax2+/− mutant embryos rarely, if ever, exhibit supernumerary
ureteric buds, duplicated ureters, or lobular kidneys. These supernu-
merary ureteric buds seen in the Paxneo/neo embryos could be due to
a reduction in Spry1 expression. Thus, as Pax2 protein levels are re-
duced even further in the PaxEneo/Eneo embryos, the need for RET acti-
vation may be less critical as Spry1 is lower.
How Pax proteins function to specify tissue morphogenesis still
remains obscure, despite decades of genetic analyses. Given their
DNA binding capacity, Pax proteins are thought to function as
transcription factors for regulating tissue and cell-type speciﬁc
genes during development. More recent studies indicate that Pax2
can provide the DNA binding speciﬁcity for an MLL3/4 Trithorax-
like protein complex that promotes histone H3, lysine 4 methylation
(H3K4me) to mark regions of active chromatin (Patel et al., 2007).
Through its interaction with PTIP, Pax2 recruits the MLL proteins
such that positive epigenetic marks are established at genes slated
for transcription activation. Similar results have been reported for
Pax5 in B cell lineage commitment (McManus et al., 2011). The Pax/
PTIP complex can also promote long-distance enhancer and promoter
interactions through chromatin looping (Schwab et al., 2011), again
suggesting effects on chromatin structure to activate gene expression.
However, Pax proteins also interact with other proteins, such as the
co-repressor Grg4/Tle4, to recruit Polycomb complexes that establish
repressive epigenetic marks on chromatin (Patel et al., 2012). Thus,
this dual potential for activation and repression may be temporally
regulated by the availability of co-factors. Whether the loss of
epithelial cell polarity is due to the failure to activate epithelial
speciﬁc genes or the failure to repress more mesenchymal speciﬁc
Fig. 6. Loss of epithelial cell polarity in Pax2mutants. Serial transverse sections through the nephric duct and adjacent mesenchyme were taken from Pax2Egfp/+ (A–D, I–L) and Pax2-
Egfp/Egfp (E–H, M–P) E11.5 embryos and immunostained with antibodies and DAPI or used for transmission electron microscopy. A) Laminin (green) and ZO1 (red) mark the colum-
nar epithelium of the nephric duct (nd). B) Pax2 (green) and ZO1 (red) mark the nephric duct, whereas the mesenchyme (m) expresses only Pax2. C) EGFP (red) is seen in the
nephric duct and mesenchyme, whereas laminin (green) only stains the basement membrane of the mature epithelia. D) Transmission EM shows cells of the nephric duct with
lateral junctions. E and F) Laminin (green) and ZO1 (red) show a disorganized nephric duct with regions of lost polarity and multiple cell layers (arrowhead). G) EGFP (red)
and Laminin (green) staining of a nephric duct shows a discontinuous basement membrane (arrows), regions of multiple cell thickness (arrowhead), and a convoluted structure.
H) Transmission EM of the nephric duct shows gaps between cells (arrow) and no evidence of tight cell junctions. I) Crumbs3 (red) is localized to all sub-apical tight junctions in
normal nephric duct. J) Occludin1 (red) is found at tight junctions and Disc Large homologue 1 (green) is expressed baso-laterally in normal nephric duct epithelia. K) N-cadherin
(green) is in the mesenchyme but not the nephric duct epithelia. L) The Laminin (red) basement membrane encircles the N-cadherin (green) negative epithelia. M) Crumbs3 (red)
is discontinuous within the abnormal epithelia of the EGFP (green) mutant nephric duct. N) Similar to Crumbs3, Occludin1 is also discontinuous in the duct epithelia, whereas Disc
Large homologue 1(green) localizes normally but with reduced intensity. O) Some N-cadherin (green) positive cells are seen within the epithelia (arrow) of Pax2 null nephric ducts.
P) Same section as O but stained with laminin (red) to outline the mutant epithelia.
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EGFP positive cells.
The loss of Pax2 and Pax8 function in the intermediate mesoderm
results in the complete absence of the nephric duct, the mesonephros,
and the metanephros, and the loss of Lhx1 and GDNF expression
(Bouchard et al., 2002). The nephric duct initially forms in Pax2 null
embryos because of the redundant function of Pax8 early in the
intermediate mesoderm. However, the periductal mesenchyme fails
to make mesonephric tubules nor is there evidence of metanephric
induction. Our data now suggest that in Pax2 null mutants, the
nephric duct forms an initial epithelial tube, as evidenced by base-
ment membrane and tight junction staining, but that these epithelial
cells lose their integrity and become mobile. Enhanced mobilitymay be due to the loss of tight and adherent junctions, which also
help establish and maintain apical–basal polarity (Wang and
Margolis, 2007). Mobility could be driven by the reduction of Spry1
expression, which leads to ureteric bud like outgrowths, although
the nodules that appear in the PaxEgfp/Egfp embryos are not as distinct
as the supernumerary ureteric buds seen in Spry1mutants (Basson et
al., 2005, 2006). The lack of c-RET expression in the mutant nephric
ducts, which has been observed previously in Pax2 null embryos
(Brophy et al., 2001), is also different than in Spry1 mutants.
The mutant nephric ducts in PaxEgfp/Egfp embryos are similar to
those observed at the posterior end of Gata3 mutants, which
exhibit multi-cellularity and outgrowths, and are consistent
with idea that Gata 3 is a target of Pax2/8 (Grote et al., 2006). The
249A. Sooﬁ et al. / Developmental Biology 365 (2012) 241–250expression of N-cadherin and the loss of tight junction proteins
also suggest a cell fate transformation occurs in the Pax2 mutant
nephric ducts, prior to any cell death that may be observed at later
stages.
If Pax2/8 are required for specifying the renal epithelial lineage in
the intermediate mesoderm, then our studies suggest that this
speciﬁcation is reversible. Thus, if Pax8 is sufﬁcient to establish the
epithelial phenotype in the nephric duct in the absence of Pax2
(Bouchard et al., 2000), continued expression of Pax2 is needed to
maintain that epithelial phenotype once Pax8 is repressed. If Pax
proteins drive epigenetic modiﬁcations, then those modiﬁcations
must be maintained. Our studies in more differentiated cells suggest
that H3K4me is needed to maintain cellular physiology and a stable
pattern of gene expression (Lefevre et al., 2010; Stein et al., 2011).
Without either Pax2 or Pax8, epithelial cells begin a transformation
toward a more mesenchymal phenotype, including loss of tight junc-
tions and cell adhesion and increased motility and migration out of
the epithelial duct. This need for Pax2/8 appears to be transient, as
differentiated, non-dividing epithelial cells of the nephron turn off
both genes. Our data suggest that the Pax2 function that maintains
the epithelial phenotype may be required only in dividing cells.
Interestingly, Pax2 is reactivated in the regenerating epithelial cells
after injury (Imgrund et al., 1999) that are derived from surviving
differentiated epithelial cells (Humphreys et al., 2008). Regenerating
epithelial cells require other developmental regulators like HNF1β
to reset epigenetic marks (Verdeguer et al., 2010), consistent with
the idea that regeneration restarts the embryonic developmental
program. These new Pax2-EGFP alleles described in this report will
prove valuable for studying such genetic and cell biological events
in both developing and regenerating kidneys.
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